B&G Foods Inc
XMUN:DHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
B&G Foods Inc
XMUN:DHR
|
US |
|
N
|
Nektar Therapeutics
XMUN:ITH
|
US |
|
N
|
Nektar Therapeutics
F:ITH
|
US |
|
B
|
B&G Foods Inc
F:DHR
|
US |
Wall St Price Targets
DHR Price Targets Summary
B&G Foods Inc
According to Wall Street analysts, the average 1-year price target for DHR is 3.627 EUR with a low forecast of 2.565 EUR and a high forecast of 4.444 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DHR's stock price target?
Price Target
3.627
EUR
According to Wall Street analysts, the average 1-year price target for DHR is 3.627 EUR with a low forecast of 2.565 EUR and a high forecast of 4.444 EUR.
What is the Revenue forecast for B&G Foods Inc?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -1%.
What is the Gross Profit forecast for B&G Foods Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for B&G Foods Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 7%.
